Security key
52490G102
- Security type / class
- Equity / Ordinary Shares
- Total 13F shares
- 2,441,557
- Total 13F value
- $70,501,015
- Share change
- +1,762,358
- SEC-reported price per share
- $28.88
- Number of holders
- 31
- Value change
- +$51,122,959
- Number of buys
- 16
- Number of sells
- 15
- Shares outstanding
- 368,659,889
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
31
Top holders
10
LEGN full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Legend Biotech Corp SEC filings
Legend Biotech Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52490G102
Recent filing periods:
Ownership snapshot
Top reported holders of LEGN - Legend Biotech Corp - Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 13%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
13%
PRICE T ROWE ASSOCIATES INC /MD/
3.7%
Ying Huang
0.06%
Darren Xiaohui Ji
0.02%
Corazon (corsee) D. Sanders
0.02%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
13%
|
$1,049,921,245
48,294,445 shares
|
-$147,815,434 | 31 Dec 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
T. Rowe Price Associates, Inc.
|
3.7%
|
$233,379,028
6,808,023 shares
|
$0 | 31 Dec 2024 |
| Ying Huang |
3/4/5
Chief Executive Officer, Director
|
0.06%
|
$4,314,284
238,490 shares
|
-$169,404 | 30 Jun 2026 |
| Darren Xiaohui Ji |
3/4/5
Director
|
0.02%
|
$1,259,516
63,773 shares
|
— | 18 Mar 2026 |
| Corazon (corsee) D. Sanders |
3/4/5
Director
|
0.02%
|
$1,167,521
59,115 shares
|
— | 18 Mar 2026 |
| Patrick John Casey |
3/4/5
Director
|
0.01%
|
$719,339
48,604 shares
|
-$88,800 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
31
Shares
2,441,557
Rows available
31
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
189
Q2 2026 holders
31
Holder diff
-158
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend